J Rad
Biographic Data
| ID | 7804148 |
|---|---|
| NAME | J Rad |
| GIVEN NAMES | J |
| FAMILY NAME | Rad |
| SIGNATURE | RAD J |
| AFFILIATIONS | University of Exeter |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Health inequities
Health inequities remain one of the most pressing global challenges, deeply rooted in socio-economic, environmental, and technological factors. These disparities, historically influenced by colonial legacies and socio-economic inequality, persist into the present, with new challenges such as the COVID-19 pandemic and climate change further widening them. Looking ahead, the rise of digital health technologies and worsening climate impacts present …
Critical discourse analysis of social media advertisements for GLP-1 receptor agonist weight loss drugs
This study conducts a critical discourse analysis (CDA) of social media advertisements (ads) for Glucagon-like peptide-1 receptor agonist (GLP-1 RAs) weight loss drugs to examine their linguistic features, discursive practices, and social implications, aiming to explore how advertising strategies may shape public perceptions and consumer considerations. Data collection focused on Facebook and Instagram, targeting ads related to FDA-approved GLP-1…
No prominent works on this page.
Health inequities
Health inequities remain one of the most pressing global challenges, deeply rooted in socio-economic, environmental, and technological factors. These disparities, historically influenced by colonial legacies and socio-economic inequality, persist into the present, with new challenges such as the COVID-19 pandemic and climate change further widening them. Looking ahead, the rise of digital health technologies and worsening climate impacts present …
Critical discourse analysis of social media advertisements for GLP-1 receptor agonist weight loss drugs
This study conducts a critical discourse analysis (CDA) of social media advertisements (ads) for Glucagon-like peptide-1 receptor agonist (GLP-1 RAs) weight loss drugs to examine their linguistic features, discursive practices, and social implications, aiming to explore how advertising strategies may shape public perceptions and consumer considerations. Data collection focused on Facebook and Instagram, targeting ads related to FDA-approved GLP-1…
Medicine (2 works) · Nursing (2 works) · Political science (2 works) · Public health (2 works) · Credibility (1 work) · Development economics (1 work) · Digital Communication and Language (1 work) · Economic growth (1 work) · Economics (1 work) · Environmental health (1 work)